drugset / Trial / NCT02024295

Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis

NCT02024295

Phase 4 Unknown 118 enrolled Zhejiang Hisun Pharmaceutical Co. Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine the efficacy and safety S-adenosyl-l-methionine in alcoholic hepatitis with cholestasis.

Timeline

Start
2013-12
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ademethionine Unknown 1000 mg Intravenous
Comparator Polyene Phosphatidylcholine Small molecule 456 mg Intravenous

Indications